389 results on '"Cenci, M. Angela"'
Search Results
2. Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
3. Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia
4. Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease
5. D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease
6. Structural‐functional properties of direct‐pathway striatal neurons at early and chronic stages of dopamine denervation.
7. Structural‐functional properties of direct‐pathway striatal neurons at early and chronic stages of dopamine denervation
8. Toxin-Based Rodent Models of Parkinson’s Disease
9. Animal models for preclinical Parkinson's research: An update and critical appraisal
10. Preface: The evolving scenario of Parkinson's research
11. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
12. Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
13. Signaling Mechanisms in l-DOPA-Induced Dyskinesia
14. On the neuronal circuitry mediating l-DOPA-induced dyskinesia
15. Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice
16. Preclinical Models of Levodopa-Induced Dyskinesia
17. Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa ‐Induced Dyskinesia
18. Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia
19. Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse
20. Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
21. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action
22. Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism
23. Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease
24. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels
25. Non-Apoptotic Caspase-3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum
26. Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa—induced dyskinesia
27. Contributors
28. Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias
29. Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia
30. Rodent models of treatment-induced motor complications in Parkinson's disease
31. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism
32. Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia
33. Cortico-Striatal Oscillations Are Correlated to Motor Activity Levels in Both Physiological and Parkinsonian Conditions
34. L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment
35. Preface
36. Molecular Mechanisms of l-DOPA-Induced Dyskinesia
37. Maladaptive striatal plasticity in l-DOPA-induced dyskinesia
38. Contributors
39. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia
40. Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia
41. Cortico-Striatal Oscillations Are Correlated to Motor Activity Levels in Both Physiological and Parkinsonian Conditions
42. Tracking Rats in Operant Conditioning Chambers Using a Versatile Homemade Video Camera and DeepLabCut
43. Reply to: Letter to Editor by Chaudhuri, Jenner, Antonini
44. Dyskinesia Matters
45. Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinsonʼs disease
46. List of Contributors
47. Utility of 6-Hydroxydopamine Lesioned Rats in the Preclinical Screening of Novel Treatments for Parkinson Disease
48. Chronic intermittent L-DOPA treatment induces changes in dopamine release
49. Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinsonʼs disease
50. Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.